<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"
                xmlns:wfw="http://wellformedweb.org/CommentAPI/"
                xmlns:dc="http://purl.org/dc/elements/1.1/"
                xmlns:sy="http://purl.org/rss/1.0/modules/syndication/">
<channel>
<title>Ambry Genetics News by Category: Multigene Panel Testing</title>
<link>https://blog.ambrygen.com/list/category/Multigene%20Panel%20Testing</link>
<description>Find the latest Ambry Genetics news by category: Multigene Panel Testing</description>
<language>en</language>
<image>
<title>Ambry Genetics Blog</title>
<link>https://blog.ambrygen.com/list/category/Multigene%20Panel%20Testing</link>
<url>https://blog.ambrygen.com/assets/img/logo/Ambry_logo_web.jpg</url>
</image>
<item>
<title>April 2025 Hereditary Cancer Menu and Reporting Updates</title>
<link>https://blog.ambrygen.com/ambry/post/377/april-2025-hereditary-cancer-menu-and-reporting-updates</link>
<description>Explains in detail the Hereditary Cancer Menu and Reporting Updates from April 2025.</description>
<pubDate>Tue, 22 Apr 25 06:13:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Navigating Hereditary Cancer Testing: Selecting the Right Multigene Panel</title>
<link>https://blog.ambrygen.com/ambry/post/370/navigating-hereditary-cancer-testing-selecting-the-right-multigene-panel</link>
<description>For healthcare providers, choosing the right hereditary cancer test and laboratory is crucial to offer the best care for their patients.</description>
<pubDate>Tue, 17 Dec 24 09:49:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>How the Ambry Patient for Life™ Program Minimizes the Need for Provider-Initiated Exome Reanalysis Requests</title>
<link>https://blog.ambrygen.com/ambry/post/366/how-the-ambry-patient-for-lifetm-program-minimizes-the-need-for-provider-initiated-exome-reanalysis-requests</link>
<description>One of the unique benefits of exome testing is the ability to return to the data from the initial analysis and reevaluate it for new, clinically relevant findings. This blog explains when to request reanalysis.</description>
<pubDate>Fri, 15 Nov 24 09:24:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Striking the Perfect Balance in Designing Hereditary Cancer Tests: The Ambry Approach</title>
<link>https://blog.ambrygen.com/ambry/post/363/striking-the-perfect-balance-in-designing-hereditary-cancer-tests-the-ambry-approach</link>
<description>Ambry's balanced approach to designing hereditary cancer tests ensures our panels remain relevant and impactful, helping clinicians manage hereditary cancer risk with confidence.</description>
<pubDate>Thu, 31 Oct 24 08:40:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment</title>
<link>https://blog.ambrygen.com/ambry/post/362/the-evolution-of-hereditary-cancer-testing-why-pan-cancer-panels-are-the-future-of-genetic-risk-assessment</link>
<description>Pan-cancer panels offer more comprehensive diagnoses, personalized risk assessments, and targeted prevention and treatment strategies.</description>
<pubDate>Thu, 17 Oct 24 08:18:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>The Evolving Landscape of Gene-Disease Validity Curation and Its Impact on Clinical Utility</title>
<link>https://blog.ambrygen.com/ambry/post/353/the-evolving-landscape-of-gene-disease-validity-curation-and-its-impact-on-clinical-utility</link>
<description>Understanding the relationship between genes and diseases is crucial for improving patient care. Gene-Disease Validity (GDV) scoring techniques continue to evolve</description>
<pubDate>Tue, 02 Jul 24 07:37:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Research Recap: Determining Gene-Disease Validity in POT1 Tumor Predisposition</title>
<link>https://blog.ambrygen.com/ambry/post/349/research-recap-determining-gene-disease-validity-in-pot1-tumor-predisposition</link>
<description>Ambry set out to determine the prevalence of cancer types in individuals with POT1 pathogenic variants (PVs) undergoing multigene panel testing (MGPT) for a broad variety of cancer indications.</description>
<pubDate>Thu, 30 May 24 06:22:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Hereditary Cancer Testing Menu Update</title>
<link>https://blog.ambrygen.com/ambry/post/284/hereditary-cancer-testing-menu-update</link>
<description>rss feeds</description>
<pubDate>Wed, 22 Jul 20 10:00:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>3 Things You Need to Know about OvaNext</title>
<link>https://blog.ambrygen.com/ambry/post/266/3-things-you-need-to-know-about-ovanext</link>
<description>OvaNext is a comprehensive genetic test for hereditary ovarian cancer designed to give you accurate and clinically meaningful information to help you offer personalized treatment, guide early detection and prevent cancer for patients and their families</description>
<pubDate>Tue, 04 Sep 18 06:26:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Quality and Experience Bring Value to Genetic Testing</title>
<link>https://blog.ambrygen.com/ambry/post/260/quality-and-experience-bring-value-to-genetic-testing</link>
<description>Ambry was founded with one goal– help patients and families. It is with this goal in mind that we design every test, accession every sample, interpret every result, and generate every report.</description>
<pubDate>Fri, 13 Jul 18 09:37:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Using Family History to Guide Cancer Prevention</title>
<link>https://blog.ambrygen.com/ambry/post/244/using-family-history-to-guide-cancer-prevention</link>
<description>For doctors who see patients with a strong family history of cancer, ordering genetic testing can provide invaluable information that can help prevent disease.</description>
<pubDate>Thu, 15 Feb 18 08:58:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Ambry Advances Understanding of Human Disease Through Epilepsy Gene Research</title>
<link>https://blog.ambrygen.com/ambry/post/203/ambry-advances-understanding-of-human-disease-through-epilepsy-gene-research</link>
<description>Ambry Advances Understanding of Human Disease through Epilepsy Gene Research</description>
<pubDate>Tue, 15 Aug 17 15:30:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>How to Build a Smarter Panel</title>
<link>https://blog.ambrygen.com/ambry/post/197/how-to-build-a-smarter-panel</link>
<description>Ambry's smart approach to gene classification allows us to deliver reports with less ambiguity and more definitive results</description>
<pubDate>Fri, 30 Jun 17 15:43:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Lynch Syndrome - It's more common than you think</title>
<link>https://blog.ambrygen.com/ambry/post/184/lynch-syndrome-it-s-more-common-than-you-think</link>
<description>Largest study of people tested with multigene panels for Lynch syndrome, which can change patient care.</description>
<pubDate>Wed, 17 May 17 13:00:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Current Genetic Testing Guidelines Miss Some Families with CDH1 Mutations</title>
<link>https://blog.ambrygen.com/ambry/post/175/current-genetic-testing-guidelines-miss-some-families-with-cdh1-mutations</link>
<description>A new study aims to describe the clinical characteristics of CDH1 mutation carriers found through MGPT and offer informed recommendations for medical management.</description>
<pubDate>Mon, 03 Apr 17 12:06:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
<item>
<title>Exome Sequencing Provides More Coverage Than You Think</title>
<link>https://blog.ambrygen.com/ambry/post/3/exome-sequencing-provides-more-coverage-than-you-think</link>
<description>New research suggests that whole exome sequencing (WES) offers similar base pair coverage to MGPT for Mendelian diseases.</description>
<pubDate>Thu, 02 Feb 17 13:35:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Multigene Panel Testing</category>
</item>
</channel>
</rss>
